Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology
Journal of the American College of Cardiology, 2015-12, Vol.66 (21), p.2362-2371 [Peer Reviewed Journal]EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2015.09.035 ;PMID: 26542657
Full text available